Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 852 results for "astrazeneca"

AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analys...

AstraZeneca plc AZN received disappointing news with Amgen AMGN announcing its intention to terminate the co-development and commercialization agreement with AstraZeneca for brodalumab due to safety issues. Amgen mentioned in its press release ... Yahoo! Finance, 1 hour ago

178 images for astrazeneca

Invezz, 10 hours ago
American Banking News - Forex, 4 days ago
The Malaysian Times, 2 days ago
Reuters UK, 2 days ago
MedIndia, 4 days ago
Yahoo! Finance, 5 days ago
9ija, 2 days ago
9ija, 2 days ago
9ija, 2 days ago
Reuters, 1 week ago

AstraZeneca share price in focus as Amgen ends psoriasis drug partnership

California-based drugmaker Amgen (NASDAQ:AMGN) is ending its partnership with AstraZeneca (LON:AZN) to develop a psoriasis treatment after observing suicidal thoughts in patients in a trial. AstraZeneca's share price rose on Friday, adding 1.10 ...
 Invezz10 hours ago Amgen ends collaboration with AstraZeneca on inflammation drug  CNBC2 days ago Suicide stunner prompts Amgen to dump brodalumab for psoriasis, walk away from AstraZeneca  FierceBiotech2 days ago UPDATE 1-Amgen ends partnership with AstraZeneca on inflammation drug  London South East2 days ago

Amgen (AMGN) Terminates Contract With AstraZeneca (AZN) On Suicide Worries

Amgen, Inc. ( NASDAQ:AMGN ) has decided to terminate its agreement to develop a drug with AstraZeneca plc (ADR) ( NYSE:AZN ), once trials revealed that the drug being developed for psoriasis and psoriatic arthritis is causing patients to become ...
 Bidness Etc3 hours ago
Business Standard

AstraZeneca to Build New Swedish Facility

Companies Published on May 19th, 2015 | by AstraZeneca plans to spend $285 million tobuild a new drug manufacturingfacility in Sodertalje, Sweden, so it can produce more drugs to be used in clinical trials, according to a article.
 Nordic Life Science4 days ago AstraZeneca to set up $285-mn biologics facility in Sweden  Business Standard6 days ago AstraZeneca to build $285 million biologics plant in sweden  Processing Magazine5 days ago MARKET REPORT: AstraZeneca reveal healthy boost to share prices  Scottish Daily Express6 days ago

AstraZeneca Set to Possibly Pullback After Yesterday's Rally of 1.96%

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $69.27 to a high of $69.87. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $69.02 on volume of 1.2 million shares. Often times ...
 Individual.com3 days ago Watch for AstraZeneca to Potentially Pullback After Gaining 1.96% Yesterday  Comtex SmarTrend3 days ago AstraZeneca Set to Possibly Rebound After Yesterday's Selloff of 1.16%  Individual.com1 week ago After Yesterday's Decline of 1.16%, AstraZeneca Offers Investors Better Value  Comtex SmarTrend1 week ago

AstraZeneca (AZN) Trading Near $67.99 Support Level

The patented option-trade picking algorithms that power's Artifical Intelligence Center found a trading opportunity with AstraZeneca Plc ("AZN) that should provide a ...
 Individual.com4 days ago AstraZeneca (AZN) Showing Support Near $68.49  Individual.com6 days ago
India Infoline

Enhancing care for Filipinos with diabetes

Astrazeneca Pharmaceuticals (Philippines) Inc. has entered into a partnership agreement with Multicare Pharmaceuticals Philippines Inc. for the sales, marketing and distribution of its Saxagliptin and Saxagliptin + Metformin
 Philippine Daily Inquirer3 days ago AstraZeneca Pharma gains on entering into agreement with AstraZeneca UK  Business Standard1 month ago AstraZeneca Pharma in pact with AstraZeneca UK; stock up 2%  Money Control1 month ago AstraZeneca Pharma enters into agreement with AZ UK  India Infoline1 month ago

Amgen terminates brodalumab co-development deal with AstraZeneca

Editor Amgen (NASDAQ:AMGN) has terminated its pact with AstraZeneca (NYSE:AZN) for the co-development and commercialization of brodalumab, an inhibitor drug aimed at treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. ...
 Seeking Alpha2 days ago Amgen Dumps AstraZeneca PLC Pact After Patients Developed Suicidal Thoughts  BioSpace2 days ago Amgen terminates brodalumab partnership with AstraZeneca  FirstWord Pharma2 days ago AstraZeneca provides update on brodalumab development programme  Noodls2 days ago

Actavis to re-launch asthma drug

Actavis plc, a specialty pharmaceutical company, has announced the re-launch of its generic version of AstraZeneca's Pulmicort RESPULES 0.25 and 0.5mg vials, which is indicated for asthma, following a decision from the US Court of Appeals for the ...
 Individual.com2 days ago

Amgen ends work on experimental psoriasis drug

Drugmakers Amgen and AstraZeneca said Friday that some patients who took an experimental psoriasis drug experienced suicidal thoughts or behavior, and Amgen said it is ending development of the drug.
 Yahoo! UK and Ireland2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
Get updated on latest news & your favorite topics right in your inbox!
More     Less